Literature DB >> 27418858

Kikuchi-Fujimoto disease and systemic lupus erythematosus.

Diego F Baenas1, Fernando A Diehl1, María J Haye Salinas2, Verónica Riva3, Ana Diller3, Pablo A Lemos4.   

Abstract

Kikuchi-Fujimoto disease, or histiocytic necrotizing lymphadenitis, is an infrequent idiopathic disorder. It has been associated with autoimmune disorders, of which systemic lupus erythematosus is the most outstanding. The basis of its diagnosis relies on the histological examination of lymph nodes, which typically reveals necrosis surrounded by histiocytes with crescentic nucleus, immunoblasts and plasma cells, and absence of neutrophils. We report the case of a 27-year-old Argentinian female patient without any relevant past medical history to demonstrate the correlation between Kikuchi-Fujimoto disease and systemic lupus erythematosus.

Entities:  

Keywords:  autoimmune disorders; febrile syndrome; histiocytic necrotizing lymphadenitis; systemic lupus erythematosus

Year:  2016        PMID: 27418858      PMCID: PMC4935008          DOI: 10.2147/IMCRJ.S106396

Source DB:  PubMed          Journal:  Int Med Case Rep J        ISSN: 1179-142X


Introduction

Kikuchi–Fujimoto disease (KFD), or histiocytic necrotizing lymphadenitis, is an infrequent idiopathic disorder.1 It is usually a self-limited condition with a good prognosis because it has a low complication rate.2 It mainly affects young women.3 The most common clinical symptoms are fever and laboratory finding of cervical lymphadenopathy associated with leukopenia.3 Cases of KFD associated with autoimmune disorders, such as systemic lupus erythematosus (SLE), have been reported.4 Herein, we describe a female patient who presented with cervical necrotizing lymphadenitis and febrile syndrome and subsequently met the diagnostic criteria for SLE.5

Case report

A 27-year-old female patient, without any relevant past medical history, presented to the clinic with a 30-day history of voluminous and tender enlargement of cervical and nuchal lymph nodes. Five days after the onset of the symptoms, the patient developed asthenia and fever of 38–39°C that responded poorly to antipyretics. A week before visiting us, the patient had symmetric arthralgias, mainly of proximal and distal interphalangeal joints of hands and elbows. On physical examination, vital signs were otherwise unremarkable. Multiple indurated, fixed, and tender lymphadenopathies were evident in the cervical and nuchal areas. Arthralgia of the proximal and distal interphalangeal joints of the hands was evident. Cardiovascular and respiratory examinations were within normal parameters. Abdominal examination was also normal. A recent occurrence of an erythematous, indolent node of diameter 5 mm was detected in the right cheek. Mucous membranes did not show any lesion. The laboratory findings are summarized in Table 1.
Table 1

Laboratory findings

Unit of measurementNormal value (reference range)Value
Leukocytesk/μL4.5–9.43.7
Hemoglobing/dLF: 11.5–14.510.21
Plateletsk/μL150–350211
Ferritinng/mL10–150984
Nammol/L135–147134
Kmmol/L3.5–54.0
Clmmol/L95–109102
Creatininemg/dL0.60–1.20.71
Blood urea nitrogenmg/dL15–5020
GOT (AST)U/L<3792
GPT (ALT)U/L<4181
GGTU/L<4939
Total bilirrubinmg/dL<1.350.27
Alkaline phosphataseU/L91–258182
LDHU/L236–4601,002
Glycemiamg/dL76–11085
ESRmm/h>2093
CRPmg/dL<0.65.65

Note: Bold values represent abnormal values.

Abbreviations: F, female; Na, sodium; K, potassium; Cl, chloride; GOT, glutamic oxaloacetic transaminase; AST, aspartate aminotransferase; GPT, glutamic pyruvic transaminase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; LDH, lactate dehydrogenase; ESR, erythrocyte sedimentation rate, CRP, C-reactive protein.

Laboratory test results showed hypochromic normocytic anemia and elevated lactate dehydrogenase, erythrocyte sedimentation rate, glutamic oxaloacetic transaminase, and glutamic pyruvic transaminase. The urine sediment analysis was normal. Institutional approval by the Hospital Privado Ethics Committee and written informed consent from the patient was obtained to report the findings of this case. Serology test results for human immunodeficiency virus (HIV), hepatitis B and C, Epstein–Barr virus, toxoplasmosis, cytomegalovirus, and parvovirus B19 were all negative. Blood culture to detect common germs, mycobacteria, and fungi were also negative. An autoimmune screen test was requested. An ultrasonography of the neck revealed bilaterally enlarged submandibular and jugular chain lymph nodes (the largest was 2 cm in diameter), with some showing signs of necrosis. Fiberoptic rhinolaryngoscopy and chest X-ray were normal. Cervical and chest computed tomography scans only showed lymph node enlargements as previously described. An abdominal computed tomography scan evidenced infracentimetric inguinal, intercavoaortic, and left lateroaortic lymph nodes of measuring up to 9 mm in diameter. It did not show hepatomegaly or splenomegaly. A cervical lymph node biopsy was performed. The histopathological report disclosed more than ninety percent of the lymph node sample showed necrosis with distortion of the normal architecture; periodic acid–Schiff, methenamine and Ziehl-Neelsen stainings were negative in the viable tissue. The polymerase chain reaction analysis of the biopsy material was negative for histoplasma, aspergillus, mycobacteria, and cytomegalovirus. Twelve days after the onset of the symptoms, the patient developed arthritis of the proximal and distal interphalangeal joints of the hands, malar rash, photosensitive erythema in the chest, and painful oral ulcers. The patient then developed generalized erytroderma in the chest, abdomen, and upper and lower limbs, as well as diffuse alopecia. Pending autoimmune screen test results were received, which revealed positive antinuclear antibodies (Hep2) with a titer of 1:320 and a speckled pattern; negative anti-double-stranded-DNA antibodies; positive anti-Ro antibodies; and negative anti-La, anti-Smith, anti-ribonucleic protein, lupus anticoagulant, and anticardiolipin antibodies. Complement proteins C3 and C4 were within normal limits. Skin biopsy showed predominantly lymphocytic perivascular dermatitis with few eosinophils and negative immunofluorescence. Owing to the nonspecific findings of the first lymph node sampling, it was decided to perform a second biopsy guided by ultrasound to select tissue with less necrosis (Figure 1). The histopathological examination of the specimen revealed scarce lymphoid tissue due to extensive geographic necrosis and numerous histiocytes diffusely laid out surrounding the necrotic foci. No polymorphonuclear neutrophils or hematoxylin bodies were observed in the sinusoidal capillaries. Immunohistochemical panels evidenced residual lymphoid tissue that expressed positive CD20, CD3, and bcl-2. AE1/AE3 immunostaining, as well as CD1 immunostaining, was negative. CD68 immunostaining was widely positive, which is consistent with KFD.
Figure 1

Cervical lymph node biopsy.

Notes: (A) Lymph node with geographic necrosis surrounded by histiocytes (hematoxylin–eosin stain, ×10 magnification). (B) Geographic necrosis and cellular detritus without the presence of polymorphonuclear neutrophils or histiocytes (hematoxylin–eosin stain, ×40 magnification). (C and D) Positive immunostaining in histiocytes with CD68 (hematoxylin–eosin stain, ×10 and ×40 magnifications). (E) Immunostaining with CD20 antibody (hematoxylin–eosin stain, ×10 magnification). (F) Negative immunostaining with CD1a antibody (hematoxylin–eosin stain, ×40 magnification).

A diagnosis of associated SLE was made because the patient presented malar rash, photosensitivity, oral ulcers, alopecia, arthritis, and positive antinuclear antibody (2012 Systemic Lupus International Collaborating Clinics classification criteria).5 The patient has begun treatment with hydroxychloroquine (200 mg/d) and prednisone (20 mg/d), with a marked improvement in the symptoms 1 week after the treatment was started and a progressive reduction in the lymphadenopathies until complete resolution after 1 month of treatment initiation.

Discussion

Histiocytic necrotizing lymphadenitis was described by Kikuchi and Fujimoto in 1972.3 It was mainly described in young adults <40 years of age.6 This disease is more prevalent in Asia, but some cases have been reported in other continents also. Its etiology is unknown, although the most accepted hypothesis is its viral–autoimmune origin.7 Three patterns of presentation of this association were found by Medline/PubMed search until 2015: KFD before the onset of SLE (30%), simultaneous occurrence of both disorders (47%), and KFD after SLE (23%). The reported cases are listed in Table 2. Our case is the first report of the coexistence of these disorders in Argentina.
Table 2

Reported cases of KFD and SLE

Simultaneous KFD and SLEKFD after SLEKFD before SLE
Hoffmann et al (1991)20Chen and Lan (1998)36: one report of four casesel-Ramahi et al (1994)41: two cases in different reports
Chua et al (1996)21Wano et al (2000)37Sanpavat et al (2006)42
Eisner et al (1996)22Bachi (2002)38Alijotas-Reig et al (2008)43
Jimenez Saenz et al (2001)23Pace-Asciak et al (2008)39Goldblatt et al (2008)44: four cases in different reports
Quintas-Cardama24 et al (2003)Londhey et al (2010)40Paradela et al (2008)45
Tanasescu et al (2003)25Sopena et al (2012)34: one report of two casesOgata et al (2010)46
Leyral et al (2005)26Ruaro et al3Sopena et al (2012)34
Santana et al12Zuo et al13
Yilmaz et al (2006)27Patra and Bhattacharya (2013)47: two cases in different reports
Mahajan et al (2007)28
Frikha et al (2008)29: two cases in different reports
Gallien et al (2008)30
Kampitak19
Shusang et al (2008)31
Aota et al (2009)32
Gionanlis et al (2009)33
Gordon et al18
Cramer et al15
Diez-Morrondo et al2
Sopena et al (2012)34
Smith and Petri (2013)35

Abbreviations: KFD, Kikuchi–Fujimoto disease; SLE, systemic lupus erythematosus.

Some cases of familial occurrence of KFD were observed in Japan within a short period of time and in a similar setting.8 Only one human leukocyte antigen (HLA)-typing study was found.9 Also, few reports of KFD proposed the possibility of familial clustering. One of them described two nontwin sisters with HLA-identical phenotype who lived contemporarily in the same environment.10 Other report showed two nontwin sisters with HLA-identical phenotype who developed the disease in different locations and 10 years apart from each other.8 A current publication described the development of KFD in four members of the same family (three confirmed cases and one possible case) at different periods of time. Its onset may be acute or subacute and may last 2 or 3 weeks.11 No studies have shown if familial cluster of KFD is present when it links with SLE. Cervical lymphadenopathy, which is usually tender to palpation, is the main clinical feature. Other lymph node regions can also be involved.12 The common presenting symptoms are fever, sweating, chills, tender lymph nodes, malaise, weight loss, and cough.12–14 The laboratory and radiologic tests available for the diagnosis are nonspecific. The common laboratory abnormalities are leukopenia, usually neutropenia; anemia; thrombocytopenia; elevated C-reactive protein and erythrocyte sedimentation rate; impaired liver function; and atypical lymphocytes on peripheral blood smear.7,12 The diagnosis is mainly made by histopathological assessment of the lymph node. Clinical and histological differential diagnoses of KFD should take into account the following diseases: non-Hodgkin lymphomas and other lymphoid malignancies; lymphadenopathies associated with connective disorders such as SLE, rheumatoid arthritis, and Still’s disease; and bacterial or viral infections such as cat scratch disease, infectious mononucleosis, herpes simplex, HIV, toxoplasmosis, tuberculosis, and atypical mycobacterial lymphadenitis.6 Because of the clinical and pathological correlation between KFD and SLE, some authors have postulated that KFD may be a clinical feature or an incomplete phase of lupus lymphadenitis.15–18 However, there are several case reports of KFD without SLE,1 which may support the fact that they are two independent entities that may commonly coexist, as it happens with most of the autoimmune diseases in susceptible subjects. In KFD, the most common histologic finding is lymph node showing geographic necrosis with foci of apoptotic cells with abundant karyorrhectic fragments surrounded by histiocytes.6 Characteristically, neutrophils and eosinophils are absent.6 Only in those cases in which the pathologist notes hematoxyphilic bodies (clusters of basophilic material within lymph node sinuses), DNA deposits in the wall of the vessels, or areas of vasculitis surrounding the necrotic foci, he or she would suggest the diagnosis of lupus lymphadenitis and not KFD.2 Immunohistochemical analysis has great value and is generally used to exclude hematologic malignancies. CD8+ T cells prevail in KFD. The histiocytes typically express myeloperoxidase, along with lysozyme. Also, positive immunostaining appeared for CD68 and CD4 in histiocytes. From a clinical approach, it is important to consider the possibility of SLE and KFD comorbidity. Usually, KFD takes a monophasic and benign course that limits itself in 1–6 months.15–18 However, if it coexists with SLE, it can have a more aggressive course and should be treated to prevent sequelae. A long-term follow-up is necessary to monitor for recurrence.19 In addition, there have been reports of death in patients with KFD and SLE due to severe infections and development of hemophagocytic syndrome.19 Our patient did not have this complication. In our case, a new ultrasonographically guided biopsy was repeated to select the lymph nodes with less necrotic tissue. We propose this strategy to reach a histological diagnosis. In order to do that, the abovementioned ancillary studies were requested and the lymph node biopsy was repeated to ultrasonographically select the lymph nodes with less necrotic tissue to reach a histological diagnosis. KFD is one of the differential diagnoses of cervical necrotizing lymphadenitis, and when it is present, it would be wise to suspect, during its clinical course, a possible association with other autoimmune conditions, such as SLE.
  45 in total

1.  Association of Kikuchi-Fujimoto's disease with SLE.

Authors:  F Goldblatt; J Andrews; A Russell; D Isenberg
Journal:  Rheumatology (Oxford)       Date:  2008-02-26       Impact factor: 7.580

Review 2.  Kikuchi disease in systemic lupus erythematosus: clinical features and literature review.

Authors:  Y H Chen; J L Lan
Journal:  J Microbiol Immunol Infect       Date:  1998-09       Impact factor: 4.399

3.  Clinical manifestations of Kikuchi's disease in southern Taiwan.

Authors:  Hsin-Liang Yu; Susan Shin-Jung Lee; Hung-Chin Tsai; Chun-Kai Huang; Yao-Shen Chen; Hsi-Hsin Lin; Shue-Ren Wann; Yung-Ching Liu; Hui-Hwa Tseng
Journal:  J Microbiol Immunol Infect       Date:  2005-02       Impact factor: 4.399

4.  [Systemic lupus erythematosus and Kikuchi-Fujimoto disease mimicking tuberculosis].

Authors:  S Gallien; M Lagrange-Xelot; Y Crabol; J Brière; L Galicier; J-M Molina
Journal:  Med Mal Infect       Date:  2008-06-18       Impact factor: 2.152

5.  Kikuchi-Fujimoto's disease: report of familial occurrence in two human leucocyte antigen-identical non-twin sisters.

Authors:  A R A Amir; S S Amr; S S Sheikh
Journal:  J Intern Med       Date:  2002-07       Impact factor: 8.989

Review 6.  Case Series: raising awareness about Kikuchi-Fujimoto disease among otolaryngologists: is it linked to systemic lupus erythematosus?

Authors:  Pia Pace-Asciak; Mindy Ann Black; Rene P Michel; Karen Kost
Journal:  J Otolaryngol Head Neck Surg       Date:  2008-12

7.  SLE Developing in a Follow-Up Patient of Kikuchi's Disease: A Rare Disorder.

Authors:  Anupam Patra; Sujit Kumar Bhattacharya
Journal:  J Clin Diagn Res       Date:  2013-04-01

8.  Kikuchi-Fujimoto Disease: analysis of 244 cases.

Authors:  Yasar Kucukardali; Emrullah Solmazgul; Erdogan Kunter; Oral Oncul; Sukru Yildirim; Mustafa Kaplan
Journal:  Clin Rheumatol       Date:  2006-03-15       Impact factor: 3.650

9.  Fatal Kikuchi-Fujimoto disease associated with SLE and hemophagocytic syndrome: a case report.

Authors:  Thatchai Kampitak
Journal:  Clin Rheumatol       Date:  2008-05-09       Impact factor: 3.650

10.  Subacute cutaneous lupus erythematosus onset preceded by Kikuchi-Fujimoto disease.

Authors:  Vito Di Lernia; Gianluigi Bajocchi; Simonetta Piana
Journal:  Dermatol Pract Concept       Date:  2014-01-31
View more
  9 in total

1.  Risk Assessment of Recurrence and Autoimmune Disorders in Kikuchi Disease.

Authors:  Hyun Joo Jung; Il Jae Lee; Seung-Hyun Yoon
Journal:  Risk Manag Healthc Policy       Date:  2020-09-22

2.  Case Report: Kikuchi: The great mimicker.

Authors:  Kevin Bryan Lo; Anna Papazoglou; Lorayne Chua; Nellowe Candelario
Journal:  F1000Res       Date:  2018-04-30

Review 3.  Kikuchi-Fujimoto Disease in Michigan: A Rare Case Report and Review of the Literature.

Authors:  Jeffrey Michael Singh; Carl Bernard Shermetaro
Journal:  Clin Med Insights Ear Nose Throat       Date:  2019-02-27

Review 4.  Self-limiting COVID-19-associated Kikuchi-Fujimoto disease with heart involvement: case-based review.

Authors:  Anna Masiak; Amanda Lass; Jacek Kowalski; Adam Hajduk; Zbigniew Zdrojewski
Journal:  Rheumatol Int       Date:  2022-01-13       Impact factor: 2.631

5.  Kikuchi-Fujimoto Disease: Diagnosis in a Relapsing Case.

Authors:  Catarina Faria; Marco Fernandes; Rui Cunha; Hugo Moreira; Rui Costa
Journal:  Cureus       Date:  2021-11-13

6.  A young girl with chronic isolated cervical lymphadenopathy found to have lupus lymphadenopathy, progressing to develop lupus nephritis: a case report.

Authors:  K P Jayawickreme; S Subasinghe; S Weerasinghe; L Perera; P Dissanayaka
Journal:  J Med Case Rep       Date:  2021-06-28

7.  Kikuchi-Fujimoto Disease in a Young African American Male.

Authors:  Ahmed Zaghloul; Corina Iorgoveanu; Andrew Polio; Aakash Desai
Journal:  Cureus       Date:  2018-04-19

8.  Case Report of Kikuchi-Fujimoto Disease from Sub-Saharan Africa: An Important Mimic of Tuberculous Lymphadenitis.

Authors:  Karishma Sharma; Fredrick Otieno; Reena Shah
Journal:  Case Rep Med       Date:  2020-01-05

Review 9.  A Case of Kikuchi-Fujimoto Disease in a 7-Year-Old African American Patient: A Case Report and Review of Literature.

Authors:  Liyoung Kim; Oksana Tatarina-Numlan; Yongmei D Yin; Minnie John; Revathy Sundaram
Journal:  Am J Case Rep       Date:  2020-08-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.